vimarsana.com

Page 3 - Exploring Mining News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Exploring Mining Podcast - Doing it Right with Cleaner Nickel; Interview with Alaska Energy Metals

Investorideas.com, a global investor news source covering mining and metals stocks releases today s edition of Exploring Mining Podcast, featuring an exclusive follow-up video interview with host.

United kingdomUnited statesBritish columbiaGregory beischerVan zantAlaska energy metals corpAlaska energy metals corporationAlaska energy metalsBritish columbia newsfile corpExploring mining podcastCali van zantExploring miningTunes appleEnergy metals corporationInterior alaskaApple podcasts

Exploring Mining Podcast - Doing it Right with Cleaner Nickel; Interview with Alaska Energy Metals (TSX-V: AEMC) (OTCQB: AKEMF)

Exploring Mining Podcast - Doing it Right with Cleaner Nickel; Interview with Alaska Energy Metals (TSX-V: AEMC) (OTCQB: AKEMF)

United statesBritish columbiaGregory beischerVan zantAlaska energy metals corporationAlaska energy metalsAlaska energy metals corpExploring mining podcastCali van zantMining podcastCleaner nickelAlaska energyEnergy metals corporationInterior alaskaApple podcastsGoogle podcasts

Mining Stocks in Play - Arizona Metals Corp (TSX: AMC) (OTCQX: AZMCF) Makes Top Gainers List on TSX

Mining Stocks in Play - Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) Makes Top Gainers List on TSX

United statesOkay mineVan zantMarc paisArizona metals corpExxon mineralsExxon minerals companyArizona metalsKay mine projectYavapai countyKay depositPaul reidExecutive chairExploring miningCali van zantCrypto corner

Gaming Stocks in Play - GameStop Corp (NYSE: GME) Rally Back On Following Funding

Gaming Stocks in Play - GameStop Corp. (NYSE: GME) Rally Back On Following Funding

Gamestop corpExchange commissionExploring miningCrypto cornerCannabis news

Biopharma stock Insmed (Nasdaq: INSM) doubles on Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis

Biopharma stock Insmed (Nasdaq: INSM) doubles on Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis

Insmed incorporated nasdaqDrug administrationInsmed incorporatedAchieves primary endpointBoth dosage strengthsStatistically significantClinically meaningful reductionPulmonary exacerbations versusMultiple secondary endpointsBoth dosage strengths versusBrensocatib well toleratedBoth dosageNew mechanismAddress rangeInsmed plansNew drug application

vimarsana © 2020. All Rights Reserved.